Clinical Biochemist | Dual Master's in Digital Health and Public Health Management | COVID-19 Expert | Leader in Clinical Diagnostics | Published Scientist.
The study investigated the efficacy of sublingual squalene, extracted from pumpkin seed oil, in reducing mortality and re-hospitalization rates among COVID-19 patients. In a randomized clinical trial involving 602 eligible patients, those who received sublingual squalene in addition to standard treatment experienced a significant decrease in mortality compared to those who received standard treatment alone. Additionally, the squalene group had a lower rate of re-hospitalization due to COVID-19. These findings suggest that sublingual squalene in microemulsion form could be an effective drug for improving outcomes in COVID-19 patients. #COVID19Treatment #Squalene #SublingualAdministration #ClinicalTrial #MortalityRate #Rehospitalization #PumpkinSeedOil #MicroemulsionFormulation